- Report
- September 2026
- 189 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- August 2026
- 130 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- October 2026
- 197 Pages
Global
From €5381EUR$5,850USD£4,584GBP
- Report
- February 2026
- 160 Pages
Global
From €3054EUR$3,320USD£2,602GBP
€3817EUR$4,150USD£3,252GBP
- Report
- May 2026
- 553 Pages
Global
From €3311EUR$3,600USD£2,821GBP
- Report
- May 2026
- 150 Pages
Global
From €4461EUR$4,850USD£3,801GBP
- Report
- May 2026
- 265 Pages
Asia Pacific
From €1380EUR$1,500USD£1,175GBP
- Report
- May 2026
- 208 Pages
Middle East, Africa
From €1380EUR$1,500USD£1,175GBP
- Report
- May 2026
- 269 Pages
North America
From €1380EUR$1,500USD£1,175GBP
- Report
- May 2026
- 268 Pages
Europe
From €1380EUR$1,500USD£1,175GBP
- Report
- February 2026
- 160 Pages
Global
From €3054EUR$3,320USD£2,602GBP
€3817EUR$4,150USD£3,252GBP
- Report
- January 2026
- 78 Pages
Global
From €3500EUR$4,076USD£3,086GBP
- Report
- January 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- September 2026
- 191 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 184 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 195 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 188 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 188 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- October 2026
- 187 Pages
Global
From €5381EUR$5,850USD£4,584GBP
- Report
- August 2026
- 90 Pages
Global
From €4369EUR$4,750USD£3,722GBP

The Human Milk Oligosaccharides (HMOs) market is a segment of the Vitamins and Dietary Supplements industry. HMOs are a type of prebiotic found in human breast milk, and are believed to have a range of health benefits. They are used in a variety of products, including infant formula, dietary supplements, and functional foods.
HMOs are gaining popularity due to their potential to improve gut health, boost immunity, and reduce the risk of certain diseases. They are also being studied for their potential to improve cognitive development in infants.
The HMOs market is driven by increasing awareness of the health benefits of HMOs, as well as the growing demand for infant formula and dietary supplements. The market is expected to grow in the coming years, as more research is conducted on the potential health benefits of HMOs.
Some companies in the Human Milk Oligosaccharides market include Abbott Nutrition, Nestle, Danone, FrieslandCampina, and Mead Johnson Nutrition. Show Less Read more